UNSPSC 51101661: Glycobiarsol

This classification denotes an antiprotozoal agent with the molecular formula C8H9AsNO5.Bi.O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E3U8347QWJ, chemically known as bismuth, (hydrogen n-glycoloylarsanilato)oxo- (8ci) but generally known as glycobiarsol, which bears US NIH Compound Identifier 16682839. European Medicines Agency schedules Glycobiarsol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07950MIG.

UNSPSC 51101661 Glycobiarsol is a Commodity code nominally identifying a specific pharmaceutical ingredient, but recent state and local solicitations tagged under this code do not reflect glycobiarsol procurement — instead, they span naloxone distribution, therapeutic pharmacy initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing vehicles. The mismatch between the code's nominal scope and the work actually being solicited suggests that either the code has been repurposed in practice or the recent opportunities are miscoded. State and local governments buying under this taxonomy are primarily counties (Seminole County, Florida), state health agencies (Texas HHS Commission), cities (Tampa), and cooperative purchasing alliances (Minnesota MMCAP), with issuing bodies ranging from emergency management and fire rescue divisions to pharmacy benefit programs and general procurement offices.

Recent activity spans four jurisdictions with the heaviest concentration in Florida and Minnesota. Seminole County posted an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county's Community Health Building and a response deadline of July 26, 2026. The Texas HHS Commission issued a Request for Information on April 3, 2026, to assess vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The City of Tampa released an IFB on March 25, 2026, for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount (capped at $10,000) and an estimated contract value of $700,000, with responses due March 13, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. The geographic spread covers Florida, Texas, and Minnesota, with MMCAP's cooperative vehicle extending to Oregon.